切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - F1 Fo-ATPase - PKG - 5-HT7 Receptors - Androgen Receptors

13件产品中的 1-10

页面
每页
清除全部
  1. ODM-201
    A8452 ODM-201
    中文名: 达洛鲁胺
    Target: Androgen Receptors
    Summary: 新一代雄激素受体抑制剂
      ≥19.95 mg/mL
      insoluble in H2O
  2. H-7 dihydrochloride
    B6342 H-7 dihydrochloride
    Target: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: 蛋白激酶抑制剂
      Soluble in DMSO
  3. Fasudil
    B3523 Fasudil
    中文名: 法舒地尔
    Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: 钙拮抗剂
      Soluble in DMSO
  4. DL-Adrenaline
    B1326 DL-Adrenaline
    中文名: DL-肾上腺素
    Target: Androgen Receptors
    Summary: 肾上腺素能受体激动剂
      ≥18.3 mg/mL
  5. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  6. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  7. BTB06584
    B3041 BTB06584
    Target: F1 Fo-ATPase
    Summary: F1F0 ATP合酶抑制剂
      ≥17.05 mg/mL
      insoluble in H2O
  8. TOK-001
    A8623 TOK-001
    中文名: 加来特龙,伽来特隆
    Target: Androgen Receptors|Cytochrome P450 (CYP450)
    Summary: CYP17抑制剂和雄激素受体(AR)拮抗剂
      ≥12.4 mg/mL
      insoluble in H2O
  9. Andarine
    A2150 Andarine
    Target: Androgen Receptors
    Summary: 雄激素受体拮抗剂
      ≥21 mg/mL
      insoluble in H2O
  10. GSK690693
    A5072 GSK690693
    Target: Akt|PKC|PKG|PKA|Prk
    Summary: ATP竞争性的Pan-AKT抑制剂
      ≥21.25 mg/mL
      insoluble in H2O

13件产品中的 1-10

页面
每页